SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-419189"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-419189" > Risk Factors for Gr...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00012124naa a2201165 4500
001oai:DiVA.org:uu-419189
003SwePub
008200914s2020 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:144217400
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4191892 URI
024a https://doi.org/10.1016/j.bbmt.2020.05.0012 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1442174002 URI
040 a (SwePub)uud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Im, Annieu Univ Pittsburgh, UPMC, Hillman Canc Ctr, Pittsburgh, PA USA.4 aut
2451 0a Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
264 1b Elsevier BV,c 2020
338 a print2 rdacarrier
520 a Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVHD after haploidentical hematopoietic cell transplantation (haplo-HCT) using PTCy. Data from the Center for International Blood and Marrow Transplant Research on adult patients with acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, or chronic myeloid leukemia who underwent PTCy-based haplo-HCT (2013 to 2016) were analyzed and categorized into 4 groups based on myeloablative (MA) or reduced-intensity conditioning (RIC) and bone marrow (BM) or peripheral blood (PB) graft source. In total, 646 patients were identified (MA-BM = 79, MA-PB = 183, RIC-BM = 192, RIC-PB = 192). The incidence of grade 2 to 4 acute GVHD at 6 months was highest in MA-PB (44%), followed by RIC-PB (36%), MA-BM (36%), and RIC-BM (30%) (P = .002). The incidence of chronic GVHD at 1 year was 40%, 34%, 24%, and 20%, respectively (P < .001). In multivariable analysis, there was no impact of stem cell source or conditioning regimen on grade 2 to 4 acute GVHD; however, older donor age (30 to 49 versus <29 years) was significantly associated with higher rates of grade 2 to 4 acute GVHD (hazard ratio [HR], 1.53; 95% confidence interval [CI], 1.11 to 2.12; P = .01). In contrast, PB compared to BM as a stem cell source was a significant risk factor for the development of chronic GVHD (HR, 1.70; 95% CI, 1.11 to 2.62; P = .01) in the RIC setting. There were no differences in relapse or overall survival between groups. Donor age and graft source are risk factors for acute and chronic GVHD, respectively, after PTCy-based haplo-HCT. Our results indicate that in RIC haplo-HCT, the risk of chronic GVHD is higher with PB stem cells, without any difference in relapse or overall survival.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Hematologi0 (SwePub)302022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Hematology0 (SwePub)302022 hsv//eng
700a Rashidi, Arminu Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA.4 aut
700a Wang, Taou Med Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Inst Hlth & Equ, Div Biostat, Milwaukee, WI 53226 USA.4 aut
700a Hemmer, Michaelu Med Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA.4 aut
700a MacMillan, Margaret L.u Univ Minnesota, Dept Pediat, Blood & Marrow Transplant Program, Minneapolis, MN 55455 USA.4 aut
700a Pidala, Josephu H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA.4 aut
700a Jagasia, Madanu Vanderbilt Univ, Med Ctr, Nashville, TN USA.4 aut
700a Pavletic, Stevenu NCI, Immune Deficiency Cellular Therapy Program, Ctr Canc Res, Bethesda, MD 20892 USA.4 aut
700a Majhail, Navneet S.u Cleveland Clin, Taussig Canc Inst, Blood & Marrow Transplant Program, 9500 Euclid Ave,CA 60, Cleveland, OH 44195 USA.4 aut
700a Weisdorf, Danielu Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA.4 aut
700a Abdel-Azim, Hishamu Univ Southern Calif, Div Hematol Oncol & Blood & Marrow Transplantat, Childrens Hosp Los Angeles, Keck Sch Med, Los Angeles, CA 90007 USA.4 aut
700a Agrawal, Vaibhavu Indiana Univ Sch Med, Div Hematol Oncol, Indianapolis, IN 46202 USA.4 aut
700a Al-Homsi, A. Sameru NYU, Langone Med Ctr, New York, NY USA.4 aut
700a Aljurf, Mahmoudu King Faisal Specialist Hosp Ctr & Res, Dept Oncol, Riyadh, Saudi Arabia.4 aut
700a Askar, Medhatu Baylor Univ, Med Ctr, Dept Pathol & Lab Med, Dallas, TX USA.4 aut
700a Auletta, Jeffery J.u Nationwide Childrens Hosp, Blood & Marrow Transplant Program, Columbus, OH USA.;Nationwide Childrens Hosp, Host Def Program, Div Hematol, Columbus, OH USA.;Nationwide Childrens Hosp, Div Oncol, Host Def Program, Columbus, OH USA.;Nationwide Childrens Hosp, Div Bone Marrow Transplant, Host Def Program, Columbus, OH USA.;Nationwide Childrens Hosp, Div Infect Dis, Host Def Program, Columbus, OH USA.4 aut
700a Bashey, Asadu Northside Hosp, Blood & Marrow Transplant Program, Atlanta, GA USA.4 aut
700a Beitinjaneh, Ameru Univ Miami, Dept Hematol & Oncol, Miami, FL USA.4 aut
700a Bhatt, Vijaya Raju Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE USA.4 aut
700a Byrne, Michaelu Vanderbilt Univ, Med Ctr, Nashville, TN USA.4 aut
700a Cahn, Jean-Yvesu CHU Grenoble Alpes, Dept Hematol, Grenoble, France.4 aut
700a Cairo, Mitchellu New York Med Coll, Dept Pediat, Div Pediat Hematol Oncol & Stem Cell Transplantat, Valhalla, NY 10595 USA.4 aut
700a Castillo, Paulu UF Hlth Shands Childrens Hosp, Gainesville, FL USA.4 aut
700a Cerny, Janu Univ Massachusetts, Med Ctr, Dept Med, Div Hematol Oncol, Worcester, MA USA.4 aut
700a Chhabra, Saurabhu Med Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA.4 aut
700a Choe, Hannahu Ohio State Univ, Wexner Med Ctr, James Comprehens Canc Ctr, Columbus, OH 43210 USA.4 aut
700a Ciurea, Stefanu Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.4 aut
700a Daly, Andrewu Tom Baker Canc Clin, Calgary, AB, Canada.4 aut
700a Diaz Perez, Miguel Angelu Hosp Infantil Univ Nino Jesus, Dept Hematol Oncol, Madrid, Spain.4 aut
700a Farhadfar, Noshau Univ Florida, Coll Med, Div Hematol Oncol, Gainesville, FL USA.4 aut
700a Gadalla, Shahinaz M.u NCI, Div Canc Epidemiol & Genet, NIH, Clin Genet Branch, Rockville, MD USA.4 aut
700a Gale, Robertu Imperial Coll London, Hematol Res Ctr, Dept Med, Div Expt Med, London, England.4 aut
700a Ganguly, Siddharthau Univ Kansas Hlth Syst, Div Hematol Malignancy & Cellular Therapeut, Kansas City, KS USA.4 aut
700a Gergis, Usamau Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA USA.4 aut
700a Hanna, Rabiu Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA.4 aut
700a Hematti, Peimanu Univ Wisconsin, Dept Med, Div Hematol Oncol Bone Marrow Transplantat, Madison, WI USA.4 aut
700a Herzig, Rogeru Univ Kentucky, Chandler Med Ctr, Louisville, KY USA.4 aut
700a Hildebrandt, Gerhard C.u Univ Kentucky, Markey Canc Ctr, Lexington, KY USA.4 aut
700a Lad, Deepesh P.u Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India.4 aut
700a Lee, Catherineu Univ Utah, Huntsman Canc Inst, Utah Blood & Marrow Transplant Program, Salt Lake City, UT USA.4 aut
700a Lehmann, Leslieu Boston Childrens Hosp, Dana Farber Canc Inst, Boston, MA USA.4 aut
700a Lekakis, Lazarosu Univ Miami, Dept Hematol & Oncol, Miami, FL USA.4 aut
700a Kamble, Rammurti T.u Baylor Coll Med, Ctr Cell & Gene Therapy, Div Hematol & Oncol, Houston, TX 77030 USA.4 aut
700a Kharfan-Dabaja, Mohamed A.u Mayo Clin, Div Hematol Oncol, Blood & Marrow Transplantat Program, Jacksonville, FL USA.4 aut
700a Khandelwal, Poojau Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplant & Immune Deficiency, Cincinnati, OH 45229 USA.;Univ Cincinnati, Dept Pediat, Cincinnati, OH USA.4 aut
700a Martino, Rodrigou Hosp Santa Creu & Sant Pau, Div Clin Hematol, Barcelona, Spain.4 aut
700a Murthy, Hemant S.u Mayo Clin, Div Hematol Oncol, Blood & Marrow Transplantat Program, Jacksonville, FL USA.4 aut
700a Nishihori, Taigau H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA.4 aut
700a O'Brien, Tracey A.u Sydney Childrens Hosp, Kids Canc Ctr, Blood & Marrow Transplant Program, Sydney, NSW, Australia.4 aut
700a Olsson, Richardu Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD),Karolinska Inst, Dept Lab Med, Stockholm, Sweden.4 aut0 (Swepub:uu)riols677
700a Patel, Sagar S.u Univ Utah, Blood & Marrow Transplant Program, Salt Lake City, UT USA.4 aut
700a Perales, Miguel-Angelu Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA.4 aut
700a Prestidge, Timu Starship Childrens Hosp, Blood & Canc Ctr, Auckland, New Zealand.4 aut
700a Qayed, Munau Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA.4 aut
700a Romee, Rizwanu Dana Farber Canc Inst, Boston, MA 02115 USA.4 aut
700a Schoemans, Heleneu Univ Hosp Leuven, Dept Hematol, Leuven, Belgium.;Katholieke Univ Leuven, Leuven, Belgium.4 aut
700a Seo, Sachikou Dokkyo Med Univ, Dept Hematol & Oncol, Mibu, Tochigi, Japan.4 aut
700a Sharma, Akshayu St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Therapy, 332 N Lauderdale St, Memphis, TN 38105 USA.4 aut
700a Solh, Melhemu Northside Hosp, Blood & Marrow Transplant Grp Georgia, Atlanta, GA USA.4 aut
700a Strair, Rogeru Rutgers State Univ, Rutgers Canc Inst New Jersey, Brunswick, NJ USA.4 aut
700a Teshima, Takanoriu Hokkaido Univ Hosp, Sapporo, Hokkaido, Japan.4 aut
700a Urbano-Ispizua, Alvarou Univ Barcelona, Hosp Clin, IDIBAPS, Dept Hematol, Barcelona, Spain.;Inst Res Josep Carreras, Barcelona, Spain.4 aut
700a Van der Poel, Marjoleinu Maastricht Univ, Med Ctr, Maastricht, Netherlands.4 aut
700a Vij, Raviu Washington Univ, Sch Med, Div Hematol & Oncol, St Louis, MO USA.4 aut
700a Wagner, John L.u Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA USA.4 aut
700a William, Basemu Ohio State Univ, Div Hematol, Columbus, OH 43210 USA.4 aut
700a Wirk, Baldeepu Penn State Canc Inst, Bone Marrow Transplant Program, Hershey, PA USA.4 aut
700a Yared, Jean A.u Univ Maryland, Dept Med, Greenebaum Comprehens Canc Ctr, Blood & Marrow Transplantat Program,Div Hematol O, Baltimore, MD 21201 USA.4 aut
700a Spellman, Steve R.u Med Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA.4 aut
700a Arora, Muktau Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA.4 aut
700a Hamilton, Betty K.u Cleveland Clin, Taussig Canc Inst, Blood & Marrow Transplant Program, 9500 Euclid Ave,CA 60, Cleveland, OH 44195 USA.4 aut
710a Univ Pittsburgh, UPMC, Hillman Canc Ctr, Pittsburgh, PA USA.b Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA.4 org
773t Biology of blood and marrow transplantationd : Elsevier BVg 26:8, s. 1459-1468q 26:8<1459-1468x 1083-8791x 1523-6536
856u http://www.astctjournal.org/article/S108387912030286X/pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-419189
8564 8u https://doi.org/10.1016/j.bbmt.2020.05.001
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:144217400

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy